Phencyclidine Increases Forebrain Monoamine Metabolism in Rats and Monkeys: Modulation by the Isomers of HA966
Jentsch J, Elsworth J, Redmond D, Roth R. Phencyclidine Increases Forebrain Monoamine Metabolism in Rats and Monkeys: Modulation by the Isomers of HA966. Journal Of Neuroscience 1997, 17: 1769-1775. PMID: 9030635, PMCID: PMC6573388, DOI: 10.1523/jneurosci.17-05-01769.1997.Peer-Reviewed Original ResearchMeSH KeywordsAction PotentialsAnimalsChlorocebus aethiopsDopamineExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsFrontal LobeIsomerismMaleNeuronsPhencyclidineProsencephalonPyrrolidinonesRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateSchizophrenic PsychologySerotoninSpecies SpecificitySubstantia NigraTegmentum MesencephaliConceptsPCP-induced increasePrefrontal cortexDA turnoverMonoamine metabolismFrontal cortexNucleus accumbensNMDA receptor antagonist phencyclidinePCP-induced changesForebrain of ratsMonkey frontal cortexEffects of PCPDrug-induced activationMedial prefrontal cortexMonoamine transmissionSerotonergic innervationDopamine innervationSerotonin turnoverDopamine turnoverSerotonin utilizationPsychotomimetic propertiesDopamine transmissionDopamine systemBrain regionsPotent effectsRatsDysregulation of Mesoprefrontal Dopamine Neurons Induced by Acute and Repeated Phencyclidine Administration in the Nonhuman Primate: Implications for Schizophrenia
Jentsch J, Elsworth J, Taylor J, Redmond D, Roth R. Dysregulation of Mesoprefrontal Dopamine Neurons Induced by Acute and Repeated Phencyclidine Administration in the Nonhuman Primate: Implications for Schizophrenia. Advances In Pharmacology 1997, 42: 810-814. PMID: 9328021, DOI: 10.1016/s1054-3589(08)60870-4.Peer-Reviewed Original ResearchConceptsPCP administrationAcute PCP administrationNegative symptomsDA systemMesoprefrontal dopamine neuronsSubcortical DA systemsBrains of patientsSchizophrenia-like symptomatologyDevelopment of neuropathologyDistinct behavioral effectsDAergic dysfunctionDA metabolismDAergic functionDopamine neuronsCognitive dysfunctionNovel agentsDeficits of schizophreniaFrontal cortexPsychotomimetic propertiesNeurobiological effectsDopamine systemPositive symptomsPhencyclidine administrationBehavioral effectsAdministration